Neurogene Inc. Quarterly Operating Income (Loss) in USD from Q2 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Neurogene Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2017 to Q3 2024.
  • Neurogene Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$22.2M, a 45.7% decline year-over-year.
  • Neurogene Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$75.8M, a 44.4% decline year-over-year.
  • Neurogene Inc. annual Operating Income (Loss) for 2023 was -$55.6M, a 1.65% increase from 2022.
  • Neurogene Inc. annual Operating Income (Loss) for 2022 was -$56.5M, a 6.89% increase from 2021.
  • Neurogene Inc. annual Operating Income (Loss) for 2021 was -$60.7M, a 80% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$75.8M -$22.2M -$6.96M -45.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-18
Q2 2024 -$68.9M -$20.1M -$7.54M -59.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$61.3M -$18.8M -$5.74M -44.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$55.6M -$14.7M -$3.06M -26.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 -$52.5M -$15.2M -$1.61M -11.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-18
Q2 2023 -$50.9M -$12.6M +$3.28M +20.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$54.2M -$13M +$2.33M +15.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$56.5M -$11.7M +$3.5M +23.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 -$60M -$13.6M +$1.84M +11.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$61.9M -$15.9M -$747K -4.94% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$61.1M -$15.4M -$417K -2.79% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$60.7M -$15.2M -$2.54M -20.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 -$58.2M -$15.5M -$13.2M -587% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$45M -$15.1M -$5.36M -54.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$39.6M -$14.9M -$5.88M -64.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$33.7M -$12.6M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 -$2.25M +$57.3M +96.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$9.77M -$9.34M -2182% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$9.07M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q3 2019 -$59.5M -$44.3M -292% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$428K -$3.12M -116% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-01
Q3 2018 -$15.2M -$3.13M -25.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $2.69M +$16.7M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q3 2017 -$12.1M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$14M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.